Related Experiment Video
Updated: Dec 30, 2025

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts
Published on: November 7, 2019
[Cardiology]
David Meier1, Stéphane Fournier1, Nicolas Barras1
1Service de cardiologie, Département cœur et vaisseaux, CHUV et Université de Lausanne, 1011 Lausanne.
Insights
New guidelines impact chronic coronary syndrome management. Research highlights benefits of TAVI, prognostic value of vegetation size in endocarditis, DAPA-HF study results for heart failure, and cardiac MRI for sudden cardiac death risk stratification.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Research
Background:
- Recent 2019 guidelines introduce "chronic coronary syndrome," impacting stable coronary artery disease management.
- Aortic stenosis treatment advancements include percutaneous aortic valve implantation (TAVI) for low-risk patients.
- Infectious endocarditis prognosis is linked to vegetation size and imaging techniques.
Purpose of the Study:
- To review recent advancements and guideline changes in cardiovascular medicine.
- To assess the impact of new evidence on patient work-up and treatment strategies.
- To highlight key findings in coronary artery disease, valvular heart disease, infectious endocarditis, and heart failure.
Main Methods:
- Literature review of recent publications and guideline updates.
- Analysis of studies on percutaneous aortic valve implantation (TAVI) and DAPA-HF trial.
- Evaluation of prognostic markers in infectious endocarditis and cardiac MRI findings.
Main Results:
- Chronic coronary syndrome guidelines alter stable coronary artery disease management.
- TAVI demonstrates benefits in low-risk aortic stenosis patients.
- Vegetation size and positron emission tomography aid endocarditis prognosis; DAPA-HF shows heart failure improvement.
- Cardiac MRI detects myocardial fibrosis for sudden cardiac death risk stratification.
Conclusions:
- Updated guidelines and new studies significantly influence cardiovascular patient care.
- Early detection and risk stratification using advanced imaging and clinical trials improve outcomes.
- Multifaceted approaches are crucial for managing complex cardiovascular conditions.
Abstract:
In 2019, the guidelines on the new entity « chronic coronary syndrome » have been published. They influence importantly the work-up and treatment of patients with stable coronary artery disease. We will also report on publications showing the benefit of percutaneous aortic valve implantation (TAVI) in patients with aortic stenosis and low risk surgical risk. With regard to infectious endocarditis, we elucidate the importance of the vegetation's size for predicting mortality and the prognostic value of the positron emission tomography in predicting septic embolism. We highlight the spectacular results of the DAPA-HF study in patients with heart failure and review publications showing the important role of the detection of myocardial fibrosis and scar by cardiac MRI for risk stratification of sudden cardiac death.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy V: Interprofessional Care
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiovascular Drugs: Classification based on Therapeutic Indications
Imaging Studies for Cardiovascular System V: CT

